Generation of Salmonella-specific Th1 cells requires sustained antigen stimulation

Vaccine

Volumn 29, Issue 15, 2011, Pages 2697-2704

  Griffin, Amanda J ^a   McSorley, Stephen J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bacterial infection; CD4 T cells; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CYTOKINE; ENROFLOXACIN; FLAGELLIN; GAMMA INTERFERON; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALMONELLOSIS VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; T LYMPHOCYTE; TH1 CELL; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; MICE; MICE, INBRED C57BL; SALMONELLA; SALMONELLA VACCINES; TH1 CELLS; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED;

EID: 79952243349     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.078     Document Type: Article

References (32)

1. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82(5):346-353.
2. Farthing M.J. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000, 14(1):65-69.
3. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N Engl J Med 2002, 347(22):1770-1782.
4. Mara D.D. Water, sanitation and hygiene for the health of developing nations. Public Health 2003, 117(6):452-456.
5. Crump J.A., Mintz E.D. Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 2010, 50(2):241-246.
6. Guzman C.A., Borsutzky S., Griot-Wenk M., Metcalfe I.C., Pearman J., Collioud A., et al. Vaccines against typhoid fever. Vaccine 2006, 24(18):3804-3811.
7. Whitaker J.A., Franco-Paredes C., del Rio C., Edupuganti S. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 2009, 16(1):46-52.
8. Acharya I.L., Lowe C.U., Thapa R., Gurubacharya V.L., Shrestha M.B., Cadoz M., et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi A preliminary report. N Engl J Med 1987, 317(18):1101-1104.
9. Hoiseth S.K., Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981, 291(5812):238-239.
10. Pasetti M.F., Levine M.M., Sztein M.B. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 2003, 21(5-6):401-418.
11. Santos R.L., Zhang S., Tsolis R.M., Kingsley R.A., Adams L.G., Baumler A.J. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 2001, 3:1335-1344.
12. Mastroeni P., Chabalgoity J.A., Dunstan S.J., Maskell D.J., Dougan G. Salmonella: immune responses and vaccines. Vet J 2001, 161(2):132-164.
13. Nauciel C. Role of CD4+ T cells and T-independent mechanisms in aquired resistance to Salmonella typhimurium infection. J Immunol 1990, 145:1265-1269.
14. - infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996, 156:3321-3326.
15. Ravindran R., Foley J., Stoklasek T., Glimcher L.H., McSorley S.J. Expression of T-bet by CD4 T cells is essential for resistance to Salmonella infection. J Immunol 2005, 175(7):4603-4610.
16. McSorley S.J., Jenkins M.K. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun 2000, 68(6):3344-3348.
17. Mastroeni P., Simmons C., Fowler R., Hormaeche C.E., Dougan G. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid aquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000, 68:46-53.
18. Cunningham A.F., Gaspal F., Serre K., Mohr E., Henderson I.R., Scott-Tucker A., et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol 2007, 178(10):6200-6207.
19. Ravindran R., McSorley S.J. Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology 2005, 114(4):450-458.
20. VanCott J.L., Chatfield S.N., Roberts M., Hone D.M., Hohmann E.L., Pascual D.W., et al. Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med 1998, 4:1247-1252.
21. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G. Early programming of T cell populations responding to bacterial infection. J Immunol 2000, 165(12):6833-6839.
22. Bajenoff M., Wurtz O., Guerder S. Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J Immunol 2002, 168(4):1723-1729.
23. Blair D.A., Lefrancois L. Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc Natl Acad Sci U S A 2007, 104(38):15045-15050.
24. Obst R., van Santen H.M., Mathis D., Benoist C. Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J Exp Med 2005, 201(10):1555-1565.
25. McSorley S.J., Asch S., Costalonga M., Rieinhardt R.L., Jenkins M.K. Tracking Salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 2002, 16:365-377.
26. Srinivasan A., Foley J., Ravindran R., McSorley S.J. Low-dose salmonella infection evades activation of flagellin-specific CD4 T cells. J Immunol 2004, 173(6):4091-4099.
27. McSorley S.J., Cookson B.T., Jenkins M.K. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J Immunol 2000, 164(2):986-993.
28. Srinivasan A., Foley J., McSorley S.J. Massive Number of Antigen-Specific CD4 T Cells during Vaccination with Live Attenuated Salmonella Causes Interclonal Competition. J Immunol 2004, 172(11):6884-6893.
29. Crum N.F. Current trends in typhoid Fever. Curr Gastroenterol Rep 2003, 5(4):279-286.
30. Cattoir V., Nordmann P. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr Med Chem 2009, 16(8):1028-1046.
31. Griffin A., Baraho-Hassan D., McSorley S.J. Successful treatment of bacterial infection hinders development of acquired immunity. J Immunol 2009, 183(2):1263-1270.
32. Srinivasan A., Salazar-Gonzalez R.M., Jarcho M., Sandau M.M., Lefrancois L., McSorley S.J. Innate immune activation of CD4 T cells in salmonella-infected mice is dependent on IL-18. J Immunol 2007, 178(10):6342-6349.